{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T16:17:51Z","timestamp":1648916271276},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T00:00:00Z","timestamp":1308268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orthop\u00e4de"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00132-011-1786-6","type":"journal-article","created":{"date-parts":[[2011,6,15]],"date-time":"2011-06-15T12:21:08Z","timestamp":1308140468000},"page":"1111-1118","source":"Crossref","is-referenced-by-count":0,"title":["Bisphosphonatinduzierte Stressfrakturen am Femur"],"prefix":"10.1007","volume":"40","author":[{"given":"R.","family":"Lenz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ellenrieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Skripitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pautke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Mittelmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,17]]},"reference":[{"key":"1786_CR1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","volume":"348","author":"Black","year":"1996","unstructured":"Black D, Cummings S, Karpf D (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348:1535\u20131541","journal-title":"Lancet"},{"key":"1786_CR2","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","volume":"350","author":"Bone","year":"2004","unstructured":"Bone H, Hosking D, Devogelaer J (2004) Ten years\u2018 experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189\u20131199","journal-title":"N Engl J Med"},{"key":"1786_CR3","unstructured":"S3-Leitlinie Osteoporose. Dachverband Osteologie eV (DVO). http:\/\/www.dv-osteologie.org 2009"},{"key":"1786_CR4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1006\/bbrc.1996.1113","volume":"224","author":"Rogers","year":"1996","unstructured":"Rogers M, Brown R, Hodkin V et al (1996) Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes. Biochem Biophys Res Commun 224:863\u2013869","journal-title":"Biochem Biophys Res Commun"},{"key":"1786_CR5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","volume":"13","author":"Luckman","year":"1998","unstructured":"Luckman S, Hughes D, Coxon F (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent posttranslational prenylation of GTP-binding proteins, including Ras. J Bone Mineral Res 13:581\u2013589","journal-title":"J Bone Mineral Res"},{"key":"1786_CR6","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","volume":"95","author":"Watts","year":"2010","unstructured":"Watts N, Diab D (2010) Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab 95:1555\u20131565","journal-title":"J Clin Endocrinol Metab"},{"key":"1786_CR7","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/BOR.0b013e32833ad677","volume":"22","author":"Abrahamsen","year":"2010","unstructured":"Abrahamsen B (2010) Bisphosphonate adverse effects, lessons from large databases. Curr Opin Rheumatol 22:404\u2013409","journal-title":"Curr Opin Rheumatol"},{"key":"1786_CR8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcms.2010.05.009","volume":"39","author":"Otto","year":"2011","unstructured":"Otto S, Abu-Id M, Fedele S et al (2011) Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: Not just a sporadic coincidence \u2013 a multi-centre study. J Craniomaxillofac Surg 39:272\u2013277","journal-title":"J Craniomaxillofac Surg"},{"key":"1786_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/BOT.0b013e3181b6499b","volume":"24","author":"Koh","year":"2010","unstructured":"Koh J, Goh S, Png M et al (2010) Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture. J Orthop Trauma 24:75\u201381","journal-title":"J Orthop Trauma"},{"key":"1786_CR10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.injury.2007.08.036","volume":"39","author":"Kwek","year":"2008","unstructured":"Kwek E, Goh S, Koh J et al (2008) An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 39:224\u2013231","journal-title":"Injury"},{"key":"1786_CR11","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","volume":"362","author":"Black","year":"2010","unstructured":"Black D, Kelly M, Genant H et al (2010) Bisphosphonates an fractures of the subtrochanteric or diaphyseal femur. N Engl J Med 362:1761\u20131771","journal-title":"N Engl J Med"},{"key":"1786_CR12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"Russell","year":"2008","unstructured":"Russell R, Watts N, Ebetino F, Rogers M (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19:733\u2013759","journal-title":"Osteoporos Int"},{"key":"1786_CR13","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"Odvina","year":"2005","unstructured":"Odvina C, Zerwekh J, Rao D et al (2005) Severely suppressed bone turnover: potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1294\u20131301","journal-title":"J Clin Endocrinol Metab"},{"key":"1786_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00223-009-9263-5","volume":"85","author":"Armamento-Villareal","year":"2009","unstructured":"Armamento-Villareal R, Napoli N, Diemer K et al (2009) Bone turnover in bone biopsies of patients with low-energy cortical fractures recieving bisphosphonates: a case series. Calcif Tissue Int 85:37\u201344","journal-title":"Calcif Tissue Int"},{"key":"1786_CR15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1098\/rstb.1984.0042","volume":"304","author":"Currey","year":"1984","unstructured":"Currey J (1984) Effects of differences in mineralization on the mechanical properties of bone. Philos Trans R Soc Lond B Biol Sci 304:509\u2013518","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1786_CR16","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00198-005-1848-x","volume":"16","author":"Richer","year":"2005","unstructured":"Richer E, Lewis M, Odvina C et al (2005) Reduction in normalized bone elasticity following long-term bisphosphonate treatment as measured by ultrasound critical angle reflectometry. Osteoporos Int 16:1384\u20131392","journal-title":"Osteoporos Int"},{"key":"1786_CR17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF03026321","volume":"23","author":"Mashiba","year":"2005","unstructured":"Mashiba T, Mori S, Burr D (2005) The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. J Bone Miner Metab 23:36\u201342","journal-title":"J Bone Miner Metab"},{"key":"1786_CR18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","volume":"28","author":"Mashiba","year":"2001","unstructured":"Mashiba T, Turner C, Hirano T (2001) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28:524\u2013531","journal-title":"Bone"},{"key":"1786_CR19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S8756-3282(02)00975-4","volume":"32","author":"Ciarelli","year":"2003","unstructured":"Ciarelli T, Fyhrie D, Parfitt A (2003) Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone 32:311\u2013315","journal-title":"Bone"},{"key":"1786_CR20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","volume":"27","author":"Boivin","year":"2000","unstructured":"Boivin G, Chavassieux P, Santora A et al (2000) Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27:687\u2013694","journal-title":"Bone"},{"key":"1786_CR21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11154-006-9008-y","volume":"7","author":"Chaiamnuay","year":"2006","unstructured":"Chaiamnuay S, Saag K (2006) Postmenopausal osteoporosis. What have we learned since the introduction of bisphosphonates? Rev Endocr Metab Disord 7:101\u2013112","journal-title":"Rev Endocr Metab Disord"},{"key":"1786_CR22","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00198-005-1945-x","volume":"16","author":"Boonen","year":"2005","unstructured":"Boonen S, Laan R, Barton I, Watts N (2005) Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies. Osteoporos Int 16:1291\u20131298","journal-title":"Osteoporos Int"},{"key":"1786_CR23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","volume":"68","author":"Lo","year":"2010","unstructured":"Lo J, O\u2019Ryan F, Gordon N et al (2010) Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 68:243\u2013253","journal-title":"J Oral Maxillofac Surg"},{"key":"1786_CR24","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1001\/archinte.1997.00440430099012","volume":"157","author":"Ensrud","year":"1997","unstructured":"Ensrud K, Black D, Palermo L et al (1997) Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med 157:2617\u20132624","journal-title":"Arch Intern Med"},{"key":"1786_CR25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3928\/01477447-20090624-27","volume":"32","author":"Goddard","year":"2009","unstructured":"Goddard M, Reid K, Johnston J, Khanuja H (2009) Atraumatic bilateral femur fracture in long-term bisphosphonate use. Orthopedics 32:607","journal-title":"Orthopedics"},{"key":"1786_CR26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00523560","volume":"114","author":"Pauwels","year":"1948","unstructured":"Pauwels F (1948) Die Bedeutung der Bauprinzipien des St\u00fctz- und Bewegungsapparates f\u00fcr die Beanspruchung langer R\u00f6hrenknochen. Z Anat 114:129\u2013166","journal-title":"Z Anat"},{"key":"1786_CR27","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/RHU.0b013e3181cf3e3d","volume":"16","author":"Breglia","year":"2010","unstructured":"Breglia M, Carter J (2010) Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy. J Clin Rheumatol 16:76\u201378","journal-title":"J Clin Rheumatol"},{"key":"1786_CR28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","volume":"22","author":"Neviaser","year":"2008","unstructured":"Neviaser A, Lane J, Lenart B et al (2008) Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma 22:346\u2013350","journal-title":"J Orthop Trauma"},{"key":"1786_CR29","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMc0707493","volume":"358","author":"Lenart","year":"2008","unstructured":"Lenart B, Lorich D, Lane J (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358:1304\u20131306","journal-title":"N Engl J Med"},{"key":"1786_CR30","first-page":"620","volume":"93","author":"Bamrungsong","year":"2010","unstructured":"Bamrungsong T, Pongchaiyakul C (2010) Bilateral atypical femoral fractures after long-term alendronate therapy: a case report. J Med Assoc Thai 93:620\u2013624","journal-title":"J Med Assoc Thai"},{"key":"1786_CR31","doi-asserted-by":"crossref","unstructured":"Capeci C, Tejwani N (2009) Bilateral low-energy simultaneous or sequential femoral fractures. J Bone Joint Surg [Am] 91:2556\u20132561","DOI":"10.2106\/JBJS.H.01774"},{"key":"1786_CR32","doi-asserted-by":"crossref","unstructured":"Goh S, Yang K, Koh J (2007) Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg [Br] 89:349\u2013353","DOI":"10.1302\/0301-620X.89B3.18146"},{"key":"1786_CR33","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1210\/jc.2007-2803","volume":"93","author":"Visekruna","year":"2008","unstructured":"Visekruna M, Wilson D, McKiernan F (2008) Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab 93:2948\u20132952","journal-title":"J Clin Endocrinol Metab"},{"key":"1786_CR34","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbmr.11","volume":"25","author":"Schwartz","year":"2010","unstructured":"Schwartz A, Bauer D, Cummings S et al (2010) Efficacy of continued alendronate for fractures in women with and without prevalent fracture: the FLEX trial. J Bone Min Res 25:976\u2013982","journal-title":"J Bone Min Res"},{"key":"1786_CR35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","volume":"47","author":"Giusti","year":"2010","unstructured":"Giusti A, Hamdy N, Papapoulos S (2010) Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case\/case series studies. Bone 47:169\u2013180","journal-title":"Bone"},{"key":"1786_CR36","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s11999-009-0725-x","volume":"467","author":"Sayed-Noor","year":"2009","unstructured":"Sayed-Noor A, Sj\u00f6d\u00e9n G (2009) Case reports: two femoral insufficiency fractures after long-term alendronate therapy. Clin Orthop Relat Res 467:1921\u20131926","journal-title":"Clin Orthop Relat Res"}],"container-title":["Der Orthop\u00e4de"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-011-1786-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00132-011-1786-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00132-011-1786-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T19:39:17Z","timestamp":1560281957000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00132-011-1786-6"}},"subtitle":["Ein neues Problem und bisherige Erkenntnisse \u2013 Fallbericht"],"short-title":[],"issued":{"date-parts":[[2011,6,17]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1786"],"URL":"https:\/\/doi.org\/10.1007\/s00132-011-1786-6","relation":{},"ISSN":["0085-4530","1433-0431"],"issn-type":[{"value":"0085-4530","type":"print"},{"value":"1433-0431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,17]]}}}